Tag

Tag: Immuno-oncology

Basel 2018 - Ulf Grawunder - Immuno-oncology

25/10/2018 5 mins

Mastering the Competitive World of Immuno-oncology

11/09/2018 5 mins

How To Break Into The Crowded Immuno-Oncology Space

Lymphocytes and cancer cells - Affimed

29/08/2018 1 min

Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B

28/08/2018 3 mins

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

29/06/2018 2 mins

Update: Yet Another ADC Company Makes Bank, This Time in Series B

14/05/2018 1 min

German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn

08/05/2018 2 mins

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

car-t immunotherapy celyad off-the-shelf

02/05/2018 2 mins

Novartis and Gilead’s CAR-T Therapies Now Compete for the Same Cancer Patients

23/04/2018 3 mins

The First CAR-T Therapy Is Not Living Up to Commercial Expectations

Cellectis Public Offering CAR-T

11/04/2018 2 mins

French CAR-T Developer Raises $164M Despite a Challenging Road

09/04/2018 4 mins

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

05/04/2018 2 mins

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

We use cookies to give you the best experience and for advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its' freely accessible content.